2022年3月18日
Association between reactogenicity and SARS-CoV-2 antibodies after the second dose of the BNT162b2 COVID-19 vaccine.
Vaccine
- 巻
- 40
- 号
- 13
- 開始ページ
- 1924
- 終了ページ
- 1927
- 記述言語
- 英語
- 掲載種別
- 研究論文（学術雑誌）
- DOI
- 10.1016/j.vaccine.2022.02.052
High vaccine reactogenicities may reflect stronger immune responses, but the epidemiological evidence for coronavirus disease 2019 (COVID-19) vaccines is sparse and inconsistent. We observed that a fever of ≥38℃ after two doses of the BNT162b2 vaccine was associated with higher severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike IgG titers.
- リンク情報
- ID情報
-
- DOI : 10.1016/j.vaccine.2022.02.052
- PubMed ID : 35183384
- PubMed Central 記事ID : PMC8841206